To all the folks who s deeply believe in the Feds spacing out doses. Have we not heard the argument on "REAL WORLD SCIENCE"? Well I would love to hear what you have to say about this... With the UK variant being the majority of cases now... As a country we are only 3% immunized with a second shot. This is like using kids "water wings" for a life jacket... So our government is worried about vaccinating kids who have a 99.99% chance full recovery, while our senior & baby boomers are still only partially vaccinated. This has turned into a political "Progressive"**** show of everyone expecting zero cases instead of keeping folks out of the hospital. Vaccine priority being given based on skin color, or socal status.. The government will lock us in our own houses, let our business and livleyhoods fall apart, while leaving the airports open to international travelers. The same travelers who have more rights to travel across the province then we do.
Our kids mental health is falling apart. We have our seniors trapped in homes not able to see their loved ones during their final days. Grandparents who have not seen grandkids in a year.. But we are vaccinating 20 yr olds & soon school kids. We will never reach herd immunity... How arrogant are we as a species that we think we can control a pandemic, or the climate. Its like saying we can control an earthquake.
"A new study has found spacing out doses of the Pfizer-BioNTech COVID-19 vaccine is a lot riskier against variants running rampant than administering both jabs quicker. The study of close to 40,000 people in Qatar found that the Pfizer-BioNtech vaccine was only 30% effective at preventing infection (either symptomatic or asymptomatic) by the B.1.1.7 variant, also known as the U.K. variant. The single shot was found to be 54.5% effective at preventing more serious results (“severe, critical or fatal”) according to the study, published in the New England Journal of Medicine on Wednesday. The study found those who have received two jabs of the vaccine had 87% protection against infection — increasing to 90% two weeks after the second dose — against the B.1.1.7 variant, which is extensively found in Ontario and Alberta.
The study was published Wednesday in the New England Journal of Medicine
calgarysun.com